DAO and schizophrenia: At present there are no drugs on the market to treat the negative symptoms and cognitive deficits of schizophrenia, and clinical trials with DAO inhibitors or D-serine have not shown a conclusive or strong effect in schizophrenia (Smith et al., 2010).